Animal Sedative Market by Type (Alpha-2 Agonists, Barbiturates, Benzodiazepines), Animal Type (Companion Animals, Equine, Livestock), Route of Administration, End-Use - Global Forecast 2024-2030
The Animal Sedative Market size was estimated at USD 80.47 million in 2023 and expected to reach USD 91.02 million in 2024, at a CAGR 13.50% to reach USD 195.28 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Animal Sedative Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Sedative Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Animal Sedative Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bimeda - MTC Animal Health, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Covetrus, Inc., Dechra Pharmaceuticals PLC, Dechra Veterinary Products Limited, Elanco Animal Health Inc., Jurox Inc., König S.A, Laboratory Drag Pharma Chile Invetec S.A., Mars, Incorporated, Merck & Co. Inc., Modern Veterinary Therapeutics LLC, NexGen Pharmaceuticals, Orion Corporation, Ouro Fino Saude Animal Group, Randlab Pty Ltd., Troy Laboratories Pty Ltd., Vedco Inc., VetOne, Vetoquinol SA, Virbac S.A., and Zoetis, Inc..
Market Segmentation & Coverage
This research report categorizes the Animal Sedative Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Alpha-2 Agonists
Companion Animals
Oral
Livestock Production Facilities
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Animal Sedative Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Sedative Market?
- What are the technology trends and regulatory frameworks in the Animal Sedative Market?
- What is the market share of the leading vendors in the Animal Sedative Market?
- Which modes and strategic moves are suitable for entering the Animal Sedative Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Animal Sedative Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising awareness among farmers about veterinary procedures
- 5.1.1.2. Growing expenditure on R&D activities for improving animal safety and care
- 5.1.1.3. Increasing government involvement in improving animal welfare
- 5.1.2. Restraints
- 5.1.2.1. Adverse health outcomes of animal sedative
- 5.1.3. Opportunities
- 5.1.3.1. Growing investments in R&D of animal sedatives
- 5.1.3.2. Emerging application of animal sedatives in medical research
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations for animal sedatives
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Animal Sedative Market, by Type
- 6.1. Introduction
- 6.2. Alpha-2 Agonists
- 6.3. Barbiturates
- 6.4. Benzodiazepines
- 6.5. Phenothiazines
- 7. Animal Sedative Market, by Animal Type
- 7.1. Introduction
- 7.2. Companion Animals
- 7.3. Equine
- 7.4. Livestock
- 8. Animal Sedative Market, by Route of Administration
- 8.1. Introduction
- 8.2. Oral
- 8.3. Parenteral
- 9. Animal Sedative Market, by End-Use
- 9.1. Introduction
- 9.2. Livestock Production Facilities
- 9.3. Veterinary Clinics & Hospitals
- 10. Americas Animal Sedative Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Animal Sedative Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Animal Sedative Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Bayer AG
- 14.1.2. Bimeda - MTC Animal Health, Inc.
- 14.1.3. Boehringer Ingelheim International GmbH
- 14.1.4. Ceva Sante Animale
- 14.1.5. Chanelle Pharma Group
- 14.1.6. Covetrus, Inc.
- 14.1.7. Dechra Pharmaceuticals PLC
- 14.1.8. Dechra Veterinary Products Limited
- 14.1.9. Elanco Animal Health Inc.
- 14.1.10. Jurox Inc.
- 14.1.11. König S.A
- 14.1.12. Laboratory Drag Pharma Chile Invetec S.A.
- 14.1.13. Mars, Incorporated
- 14.1.14. Merck & Co. Inc.
- 14.1.15. Modern Veterinary Therapeutics LLC
- 14.1.16. NexGen Pharmaceuticals
- 14.1.17. Orion Corporation
- 14.1.18. Ouro Fino Saude Animal Group
- 14.1.19. Randlab Pty Ltd.
- 14.1.20. Troy Laboratories Pty Ltd.
- 14.1.21. Vedco Inc.
- 14.1.22. VetOne
- 14.1.23. Vetoquinol SA
- 14.1.24. Virbac S.A.
- 14.1.25. Zoetis, Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ANIMAL SEDATIVE MARKET RESEARCH PROCESS
- FIGURE 2. ANIMAL SEDATIVE MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANIMAL SEDATIVE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANIMAL SEDATIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANIMAL SEDATIVE MARKET DYNAMICS
- FIGURE 7. ANIMAL SEDATIVE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ANIMAL SEDATIVE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
- FIGURE 10. ANIMAL SEDATIVE MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANIMAL SEDATIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 12. ANIMAL SEDATIVE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ANIMAL SEDATIVE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 14. ANIMAL SEDATIVE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ANIMAL SEDATIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ANIMAL SEDATIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL SEDATIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ANIMAL SEDATIVE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ANIMAL SEDATIVE MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook